ThursdayMay 21, 2026 2:59 pm

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Advancing Montauban Project with Low CapEx Strategy

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold (CSE: ESAU) (OTCQB: ESAUF) was featured in a recent article that discussed its low CapEx strategy that includes funding from a private placement initiative and an agreement with Ocean Partners UK Ltd. that provides a credit facility and a dedicated buyer of gold and silver produced from its planned tailings cleanup operation. The publication reads, “Despite market fluctuations, gold has effectively doubled in value since January 2025 and is expected to remain at near-record levels in the coming months, benefiting companies positioned to provide supply for continued…

Continue Reading

ThursdayMay 21, 2026 1:17 pm

QualityStocksNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Highlights Continued Support for Historic Clayton Silver Mine Development

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX (CSE: CXC) (OTC: CXXMF), an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, recently announced the exercise of a total of 3,320,000 warrants for the purchase of 3,320,000 common shares at $0.10 a share. “In addition, debentures aggregating $190,000 of principal were converted into 1,520,000 shares at a conversion price of $0.125 a share,” an article discussing this reads. “The exercise of warrants and conversion of debentures demonstrates the confidence of management, directors, and supporting shareholders in CMX’s plan to advance…

Continue Reading

ThursdayMay 21, 2026 12:52 pm

QualityStocksNewsBreaks – Why SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Is ‘One to Watch’

Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising. SureNano Science (CSE: SURE) (OTCQB: SURNF), a Canadian life sciences company, is positioning itself within one of the most significant pharmaceutical developments of this generation: the rapid rise of GLP-1–based therapies for obesity and metabolic disease. “Blockbuster drugs such as Ozempic(R), Wegovy(R), and Mounjaro(R) have demonstrated both strong clinical outcomes and massive commercial success, driving intense competition among large pharmaceutical companies to develop next-generation treatments,” a recent article reads. “Within this landscape, SureNano represents a smaller, more agile entrant seeking to advance its own differentiated GLP-based therapeutic.…

Continue Reading

ThursdayMay 21, 2026 11:37 am

QualityStocksNewsBreaks – GlobalTech Corp. (OTC: GLTK) Reports Q1 Revenue Growth, Advances Portfolio Integration Strategy 

GlobalTech (OTC: GLTK) reported first-quarter 2026 net revenue of approximately $10.4 million, up from approximately $4.3 million in the prior-year period, primarily driven by contributions from its 51% ownership interest in 123 Investments Limited, operator of the Moda in Pelle premium footwear platform, acquired in December 2025. The company reported total assets of approximately $100.8 million and shareholders’ equity of approximately $36.1 million as it continues integrating its expanded operating portfolio. To view the full press release, visit https://ibn.fm/oxZRh About GlobalTech Corporation GlobalTech Corporation is a publicly traded technology platform company focused on acquiring, integrating, and scaling operating businesses across telecommunications, artificial intelligence, data infrastructure, and consumer-facing digital platforms. The…

Continue Reading

ThursdayMay 21, 2026 11:26 am

QualityStocksNewsBreaks – Resilient Energy Inc. (OTCID: RENI) Forms Joint Venture to Expand Oilfield Services Operations 

Resilient Energy (OTCID: RENI) announced that its wholly owned subsidiary, Bullet SWD LLC, has entered into a joint venture agreement with an established U.S.-based oilfield services operator generating more than $15 million in annual revenue, with a customer base that includes multiple Fortune 500 energy companies. Under the agreement, RENI will supply and maintain specialized equipment supporting saltwater disposal and related oilfield operations, with the company expecting the partnership to create a high-margin revenue stream and begin generating initial revenue before the end of summer 2026. To view the full press release, visit https://ibn.fm/IVTVS About Resilient Energy Inc. Resilient Energy Inc. (OTC: RENI) is…

Continue Reading

ThursdayMay 21, 2026 11:15 am

Oncotelic Therapeutics Inc. (OTLC) Proving Small Biotech Can Out-Innovate Big Pharma with 28 Million Reasons Why

The global AI in drug-discovery market was valued at approximately $3.25 billion in 2026 and is projected to reach more than $10 billion by 2031. Oncotelic's central technology, the PDAOAI platform, was designed from the outset to be something more than a research accelerator for internal programs. The most significant development to date came when Oncotelic announced the successful integration of approximately 28 million scientific abstracts, into its PDAOAI platform. Artificial intelligence is no longer a buzzword in the life sciences; rather, it is rapidly becoming the defining infrastructure layer of modern drug development. The companies that control the most intelligent platforms…

Continue Reading

ThursdayMay 21, 2026 11:08 am

QualityStocksNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Launches MyndSystem Cognitive Support Platform 

BioAdaptives (OTC: BDPT) a science-driven health and wellness company, announced the launch of MyndSystem, a dual-phase cognitive support platform combining its daytime MyndMed formula with newly released nighttime recovery product MyndRenew into a 24-hour stimulant-free cognitive support system. The company said MyndSystem was originally developed for professional combat athletes and is designed to address both daytime mental performance and overnight neural recovery. MyndMed is a 12-ingredient daytime formula intended to support focus, mental clarity and cognitive endurance, while MyndRenew is a 14-ingredient nighttime formula designed to support the brain’s overnight repair processes, according to the company. BioAdaptives said the complete MyndSystem platform is now available for purchase as a 30-day supply through direct purchase or subscription. To view…

Continue Reading

ThursdayMay 21, 2026 10:45 am

QualityStocksNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising. Optimi Health (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) announced the pricing of its underwritten public offering in connection with its uplisting to the Nasdaq Capital Market, offering 2.4 million common shares at US$6.25 per share for expected gross proceeds of approximately US$15 million, excluding any exercise of the underwriter’s option to purchase up to an additional 360,000 shares. Joseph Gunnar & Co. LLC is acting as sole book-running manager for the offering, with trading on Nasdaq expected to begin May 20, 2026, under the…

Continue Reading

ThursdayMay 21, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Doubling Down on Clayton Silver Mine Exploration Amid Upturn in Silver Prices

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, continues to bolster its foundations amid surging demand for silver With its 100%-owned Clayton Silver Project, the company is looking to unlock its largely untapped potential, ultimately stamping its position as an integral player in the global silver production market In May 2026, the company announced that it’s making good progress on a non-brokered private placement financing for aggregate gross proceeds of up to CAN$2,000,000, with…

Continue Reading

ThursdayMay 21, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Expands AI Voice Platform with Fatigue Detection Module

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is expanding its AI voice analytics platform to include fatigue detection alongside drug and alcohol impairment screening. MindBio filed a patent application covering detection of neurologically active substances and fatigue through voice analysis. Fatigue prediction module will be added to Edge AI Intoxication Detection Kiosks targeted at industrial workplaces. Management says commercial testing of kiosk hardware and software remains on track for late Q2 2026. The company is positioning its technology as a non-invasive alternative to breath, saliva, blood and laboratory-based testing…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered